Company news

Aptose Biosciences Inc news in 2014

Aptose Biosciences Inc's news releases, calls and decks from 2014, newest first.

View company

Aptose Biosciences Announces Appointment of Dr. Erich Platzer to Board of Directors

December 15, 2014

Aptose Biosciences Presents APTO-253 Preclinical Data at 56th American Society of Hematology Annual Meeting

December 9, 2014

Aptose Biosciences to Present at Oppenheimer & Co. 25th Annual Healthcare Conference

December 5, 2014

Aptose Biosciences to Present Preclinical Research Update for APTO-253 at the 56th American Society of Hematology Annual Meeting

December 3, 2014

Aptose Biosciences to Present at The Stifel 2014 Healthcare Conference

November 17, 2014

Aptose Biosciences reports results for the four months ended September 30, 2014

November 4, 2014

Aptose Biosciences To Host Conference Call and Webcast For Four Month Interim Period Ended September 30, 2014

October 30, 2014

Aptose Biosciences Announces Approval for Listing on the NASDAQ Capital Market Shares to Begin Trading Under the Symbol APTO

October 21, 2014

Aptose Biosciences to Present at the 2014 BIO Investor Forum

October 3, 2014

Aptose Biosciences Announces Reverse Stock Split

October 1, 2014

Aptose Biosciences Joins The Leukemia & Lymphoma Society's Groundbreaking Beat AML Research Initiative with Oregon Health & Science University

September 29, 2014

Aptose Biosciences to Present at Upcoming Investor Conferences

September 25, 2014

Aptose Biosciences Recruits Stephen B. Howell, M.D. to Act in the Capacity of Chief Medical Officer

September 8, 2014

Lorus Therapeutics Implements Name Change to Aptose Biosciences

September 2, 2014

Lorus Therapeutics Announces Results of Annual and Special Meeting of Shareholders

August 19, 2014

Lorus Therapeutics Proposes Name Change to "APTOSE BIOSCIENCES" and Share Consolidation for Potential NASDAQ Listing

July 15, 2014